Cambridge Antibody Technology
Cambridge Antibody Technology (officially Cambridge Antibody Technology Group Plc, informally CAT) was a biotechnology company headquartered in Cambridge, England, United Kingdom. Its core focus was on antibody therapeutics, primarily using phage display and ribosome display technology.
known for
Wikipage disambiguates
primaryTopic
Cambridge Antibody Technology
Cambridge Antibody Technology (officially Cambridge Antibody Technology Group Plc, informally CAT) was a biotechnology company headquartered in Cambridge, England, United Kingdom. Its core focus was on antibody therapeutics, primarily using phage display and ribosome display technology.
has abstract
Cambridge Antibody Technology ...... quent acquisition speculation.
@en
assets ($)
equity ($)
extinction year
fate
Acquired byAstraZenecain 2006; combined withMedImmunein 2007
@en
foundation place
founding year
internationally
key person
net income ($)
number of employees
operating income ($)
owner
owning company
product
revenue ($)
service
successor
thumbnail
Wikipage page ID
23,574,418
Wikipage revision ID
744,552,369
area served
footnotes
*Financials for six-month peri ...... es payable on Adalimumab sales
industry
Biopharmaceutical
subject
hypernym
comment
Cambridge Antibody Technology ...... d ribosome display technology.
@en
label
Cambridge Antibody Technology
@en
wasDerivedFrom
depiction
isPrimaryTopicOf
name
Cambridge Antibody Technology Group Plc
@en